Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Millennium & Copthorne Hotels (MLC) Share Price

There is currently no data for MLC.L

Millennium & Copthorne Hotels (MLC) Share Price History

Time period:
to
Date Open High Low Close Volume
See more Millennium & Copthorne Hotels price history

Millennium & Copthorne Hotels (MLC) Share News

IN BRIEF: Malin completes oversubscribed EUR150 million tender offer

21st Mar 2025 17:54

Malin Corp PLC - Dublin-based investor in life sciences companies - Announces results of tender offer, which closed on Thursday. Says the offer was oversubscribed to the maximum 14.6 million ordinary shares will be acquired for approximately EUR150 million in total. This represents around 77.1% of Malin's issued ordinary share capital as of Friday. Read More

UK shareholder meetings calendar - next 7 days

6th Mar 2025 13:48

Read More

Roche to close USD1.5 billion acquisition of biopharma firm Poseida

8th Jan 2025 08:48

(Alliance News) - Roche Holding AG on Wednesday said that it has completed the tender offer for all outstanding shares of Poseida Therapeutics Inc, a clinical-stage biopharmaceutical company, through its wholly owned subsidiary Blue Giant Acquisition Corp. Read More

UK shareholder meetings calendar - next 7 days

19th Sep 2024 14:31

Read More

IN BRIEF: Malin intrinsic equity value falls in half-year

27th Aug 2024 19:02

Malin Corp PLC - Dublin-based investor in life sciences companies - Reports intrinsic equity value of EUR6.44 at June 30 half-year end, down 1.8% from EUR6.56 at end of December. Declines further to EUR6.33 as at August 22. Attributes decline to lower Poseida share price and a downward revision of its interest in Viamet. Says further studies by Viament on Vivjoa have delayed commercial launches and associated royalties as Viament seeks to receive extended approval for Vivjoa. "We expect further clarity on the future regulatory, commercial and strategic pathway in the months ahead," Malin says. Further, cash position at August 22 increases to EUR62.9 million, from EUR35.7 million at end of June, owing to its divestment of CG Oncology, company says. Divestment generated cash proceeds of about EUR28.5 million, a 175% gain on total capital invested. Read More

See more Millennium & Copthorne Hotels news
FTSE 100 Latest
Value8,634.80
Change0.00

Login to your account

Forgot Password?

Not Registered